Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.
J Immunother Cancer
; 9(1)2021 01.
Article
in En
| MEDLINE
| ID: mdl-33472856
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Shock, Septic
/
Receptors, Antigen, T-Cell
/
Immunotherapy, Adoptive
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Cytokine Release Syndrome
Type of study:
Diagnostic_studies
Limits:
Adult
/
Child, preschool
/
Female
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Type:
Article
Affiliation country:
United States